KFDA To Ban 1000-plus Generic Drugs In New Blow To Korea's Domestic Pharmaceutical Companies, Potential Boost For Innovative Medicines
This article was originally published in PharmAsia News
Executive Summary
SEOUL - As regulators tighten checks for safety and effectiveness on South Korea's generic drugs, they have marked 1,226 products, or 58.5 percent of the 2,095 drugs examined, for elimination from the market